(19)

(11)

EP 3 880 690 A2

(12)

(88) Date of publication A3: 25.06.2020 (43) Date of publication: 22.09.2021 Bulletin 2021/38 (21) Application number: 19883897.1 (22) Date of filing: 14.11.2019

(51) International Patent Classification (IPC):  C07K 7/06(2006.01) A61P 27/02(2006.01) A61K 9/00(2006.01) A61K 38/00(2006.01) (52) Cooperative Patent Classification (CPC): C07K 7/06 (86) International application number: PCT/IB2019/001220 (87) International publication number: WO 2020/099925 (22.05.2020 Gazette 2020/21)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 14.11.2018 US 201862767180 P (71) Applicant: YUYU Pharma, Inc. Seoul 045-046 (KR)	(72) Inventors: BAIK, Taegon Eunpyung Gu Seoul 03311 (KR) CHOI, Jong-Yun Cheongju-si Chungcheongbuk-do 28611 (KR) MIN, Gyoung-Wook Yongin-si Gyeonggi-do 16805 (KR) PARK, Chun Ho Yongin-si, Gyeonggi-do (KR) (74) Representative: HGF  1 City Walk Leeds LS11 9DX Leeds LS11 9DX (GB)